Xenetic Biosciences is trading 7.46% down at $1.86 as broad U.S. markets fall sharply on November 5, 2026. - Supplied market context reports the Nasdaq down 4.69% and the S&P 500 down 3.03%, consistent with risk-off pressure; no direct company-specific cause is confirmed. - The latest company announcement located was dated November 4 and concerned a planned ASH conference presentation. No November 5 company-specific announcement was found in the company’s latest-news listings.